Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy.

Kosch, M

Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy. [electronic resource] - Clinical nephrology Dec 2001 - S35-6 p. digital

Publication Type: Comparative Study; Letter

0301-0430


Adult
Antilymphocyte Serum--adverse effects
Cyclosporine--adverse effects
Humans
Immunosuppressive Agents--adverse effects
Incidence
Kidney Transplantation--immunology
Middle Aged
Muromonab-CD3--adverse effects
Neoplasms--chemically induced
Prednisolone--adverse effects
Retrospective Studies